Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction - A preliminary study

Citation
Me. Sullivan et al., Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction - A preliminary study, INT ANGIOL, 20(3), 2001, pp. 195-199
Citations number
55
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
INTERNATIONAL ANGIOLOGY
ISSN journal
03929590 → ACNP
Volume
20
Issue
3
Year of publication
2001
Pages
195 - 199
Database
ISI
SICI code
0392-9590(200109)20:3<195:FL(ALI>2.0.ZU;2-M
Abstract
Background. Erectile dysfunction is associated with cardiovascular risk fac tors (e.g. hypertension, smoking, dyslipidemia and diabetes) and is more co mmon in patients with cardiovascular disease. We therefore assessed the pre valence of two predictors of vascular events, fibrinogen and lipoprotein-a, in patients with and without erectile dysfunction. Methods. Men with erectile dysfunction (48 non-smokers 48 smokers), aged 45 -70 years, were compared with controls (21 non-smokers, 21 smokers) with no rmal erectile function and no known pathology. Results. Serum total cholesterol was significantly higher in non-smokers wi th erectile dysfunction compared to both control non-smokers and erectile d ysfunction smokers. Men with erectile dysfunction who smoked had a signific antly higher plasma fibrinogen level than control smokers. Similarly, men w ith erectile dysfunction, who did not smoke had higher levels of plasma fib rinogen compared to both smokers and non-smokers without erectile dysfuncti on. No significant difference in serum lipoprotein-a values was found. Conclusions. These findings support the concept that cardiovascular risk fa ctors are predictors of erectile dysfunction and that this may be another m anifestation of vascular disease.